The etiology of anxiety disorders

Orhan DOĞAN (Üsküdar Üniversitesi, İstanbul, Türkiye)
Anadolu Psikiyatri Dergisi
1 0
Yıl: 2012 Cilt: 13 Sayı: 3 Sayfa Aralığı: 224 - 231 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

The etiology of anxiety disorders

Öz:
ÖZET Anksiyete bozuklukları tüm dünyada giderek büyüyen bir sağlık sorunudur. Anksiyete bozuklukları işlevsel bozukluğa neden olduğu, yaşam kalitesini düşürdüğü ve yüksek komorbidite gösterdiği için toplum ruh sağlığı açısından çok önemlidir. Anksiyete bozukluklarının etiyolojisiyle ilgili çok sayıda araştırma olmakla birlikte, birçok psikiyatrik bozuk- lukta olduğu gibi görece yeterli düzeyde anlaşılmadan kalmıştır. Bu yazıda, anksiyete bozukluklarının biyolojik, ruhsal, bilişsel-davranışçı ve sosyal etkenler gibi etiyolojik etkenleri gözden geçirilmiştir. (Anatolian Journal of Psychiatry 2012; 13:224-231)
Anahtar Kelime:

Konular: Psikiyatri

Anksiyete bozukluklarının etiyolojisi

Öz:
Anxiety disorders are a growing health problem world-wide. They are very important from point of view of community mental health because they cause functional impairment, decrease quality of life, and have the high comorbidity. Although there are many investigations about the etiology of anxiety disorders, the causative factors, etiology, and underlying mechanisms of anxiety disorders, as for most psychiatric disorders, remain relatively poorly understood. In this article, it has been reviewed that the etiological factors of anxiety disorders such as biological, psychological, Cognitive and Behavioral, and social factors. (Anatolian Journal of Psychiatry 2012; 13:224-231)
Anahtar Kelime:

Konular: Psikiyatri
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • Dogan O. Epidemiology of anxiety disorders. NK Oğuzha- noğlu, (Ed.), Türkiye Klinikleri Psikiyatri Special Issue 2010; 3:9-18.
  • Dogan O. Psychiatric Epidemiology. Sivas, Esform Ofset, 2011, p.285-308. (In Turkish)
  • Hollander E, Simeon D. Anxiety disorders. RE Hales, SC Yudofsky, GO Gabbard, (Eds.), Textbook of Psychiatry, fifth ed., Washington, DC, American Psychiatric Publishing, 2008, p.505-607.
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Ed., Text Revision, Washington, DC, American Psychiatric Association, 2000.
  • World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva, World Health Organization, 1992.
  • Sharpe M, Baldwin D, Walker J. Neurotic, stress-related and somatoform disorders. EC Johnstone, DC Owens, SM Lawrie, AM McIntosh, M Sharpe, (Eds.), Companion to Psychiatric Studies, eight ed., Edinburgh, Elsevier, 2010, p.453-491.
  • Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Panic disorder in women: a population-based twin study. Psychol Med 1993; 23:397-406.
  • Freitag CM, Domschke K, Rothe C, Lee YJ, Hohoff C, Gutknecht L, et al. Interaction of serotonergic and noradrenergic gene variants in panic disorder. Psychiatr Genet 2006; 16:59-65.
  • Nakamura K, Yamada K, Iwayama Y, Toyota T, Furukawa A, Takimoto T, et al. Evidence that Variation in the peripheral benzodiazepine receptor (PBR) gene influences susceptibility to panic disorder. Am J Med Genet Part B Neuropsychiatr Genet 2006; 141B:222-226.
  • Fyer AJ, Mannuzza S, Gallops MS, Martin LY, Aaronson CGorman JM, et al. Familial transmission of simple phobias and fears: a preliminary report. Arch Gen Psychiatry 199047:252-256.
  • Skre I, Onstad S, Torgensen S, Lygren S, Kringlen E. A win study of DSM-III-R anxiety disorders, Acta PsychiatScand 1993; 88:85-92.
  • Chartier MJ, Walker JR, Stein MB. Social phobia and potential childhood risk factors in a community samplePsychol Med 2001; 31:307-315.
  • Gelernter J, Page GP, Stein MB, Woods SW. Genomewide linkage scan for loci predisposing to social phobiaevi-dence for a chromosome 16 locus. Am J Psychiatry 2004; 161:59-66.
  • Nestadt G, Grados M, Samuels JF. Genetics of obsessivecompul-sive disorder. Psychiatr Clin North Am 201033.141-158.
  • Bolton D, Rijsdijk F, O’Connor TG, Perrin S, Eley TCObsessive-compulsive disorder, tics and anxiety in 6-yearold twins. Psychol Med 2007; 37:39-48.
  • Meira-Lima I, Shavitt RG, Miguita K, Ikenaga E, Miguel ECVallada H. Association analysis of the Cathecol-O-Methylransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polimorphisms with obsessive compulsive disorder. Genes Brain Behav 20043:75-79.
  • Hanna GL, Veenstra-VanderWeele J, Cox NJ, Van Etten M, Fischer DJ, Himle JA, et al. Evidence for a susceptibility ocus on chromo-some 10p15 in early-onset obsessivecompulsive disorder. Biol Psychiatry 2007; 62:856-862.
  • Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJGeneralized anxiety disorder in women: a populationbased twin study. Arch Gen Psychiatry 1992; 49:267-272.
  • Nutt DJ, Malizia AL. New Insights into receptor in psychiatric disorder. Br J Psychiatry 2001; 179:390-396.
  • Deakin JF. The role of serotonin in panic, anxiety and depression. Int Clin Psychopharmacol 1998. 13(Suppl.4):S1S5.
  • Nutt DJ. Pharmacoendocrine studies in anxiety. Clin Neuropharmacol 1992; 15(Suppl.1,Pt A): 214A-215A.
  • Roy-Byrne PP, Cowley DS, Greenblatt DJ, Shader RI, Hommer D. Reduced benzodiazepine sensitivity in panic disorder. Arch Gen Psychiatry 1990; 47:534-538.
  • Nutt DJ, Glue P, Lawson C, Wilson S. Flumazenil provocation of panic attacks: evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry 1990; 47:917-925.
  • Strohle A, Kellner M, Holsboer F, Wiedemann K. Behavoral, neuroendocrine, and cardiovascular response to lumazenil: no evidence for an altered benzodiazepine eceptor sensitivity in panic disorder. Biol Psychiatry 1999; 45:321-326.
  • Johnson MR, Marazziti D, Brawman-Mintzer O, Emmanuel NP, Ware MR, Morton WA, et al. Abnormal peripheral benzodiazepine receptor density associated with generalzed social phobia. Biol Psychiatry 1998; 43:306-309.
  • Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA, et al. Reduced serotonin type 1A re- ceptor binding in panic disorder. J Neurosci 2004; 24:589- 591.
  • Maron E, Kuikka JT, Shlik J, Vasar V, Vanninen E, Tiihonen J. Reduced brain serotonin transporter binding in patient with panic disorder. Psychiatry Res 2004; 132:173-181.
  • Tancer ME, Mailman RB, Stein MB, Mason GA, Carson SW, Golden RN. Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia. Anxiety 1994; 5:216-223.
  • Argyropoulos SV, Hood SD, Androver M, Bell CJ, Rich AS, Nash JR, et al. Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biol Psychiatry 2004; 56:503-509.
  • Flament MF, Rapoport JL, Murphy DL, Berg CJ, Lake CR. Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder. Arch Gen Psychiatry 1987; 44:219-225.
  • Swedo SE, Leonard HL, Kruesi MJP, Rettew DC, Listwak SJ, Berrettini W, et al. Cerebrospinal fluid neurochemstry in children and adolescents with obsessive-compulsive disor- der. Arch Gen Psychiatry 1992; 49:29-36.
  • Adams KH, Hansen ES, Pinborg LH, Hasselbalch SG, Svarer C, Holm S, et al. Patients with obsessive compul- sive disorder have increased 5-HT2A receptor binding in he caudate nuclei. Int J Neuropsychopharmacol 2005; 8:391-401.
  • Senkowski D, Linden M, Zubragel D, Bar T, Gallinat J. Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. Biol Psychiatry 2003; 53:304-314
  • Young EA, Breslau N. Cortisol and catecholamines in postraumatic stress disorder: an epidemiologic community study. Arch Gen Psychiatry 2004 61:394-401.
  • Geracioti TD Jr, Baker DG, Ekhator NN, West SA, Hill KK, Bruce AB, et al. CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry 2001; 158:1227-1230.
  • Denys D, van der Wee N, Janssen J, De Geus F, Westenberg HG. Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Biol Psychiatry 2004; 55:1041-1045.
  • Pittenger C, Krystal JH, Coric V. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive compulsive disorder. NeuroRx 2006; 3:69-81.
  • Chakrabarty K, Bhattacharyya S, Christopher R, Khanna S. Glutamatergic dysfunction in OCD. Neuropsychopharmaclogy 2005; 30:1735-1740.
  • Altemus M, Swedo SE, Leonard HL, Richter D, Rubinow DR, Potter WZ, et al. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. Arch Gen Psychiatry 1994; 51:794- 803.
  • Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, et al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder: comparison with Tourette’s syndrome and healthy controls. Arch Gen Psychiatry 1994; 51:782-792.
  • Yehuda R. Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications. Ann N Y Acad Sci 2006; 1071:137-166.
  • Liebowitz MR, Gorman JM, Fyer AJ, Levitt M, Dillon D, Levy G, et al. Lactate provocation of panic attacks, II: biochemical and physiological findings. Arch Gen Psychiatry 1985; 42:709-719.
  • Gorman JM, Askanazi J, Liebowitz MR, Fyer AJ, Stein J, Kinney JM, et al. Response to hyperventilation in a group of patients with panic disorder. Am J Psychiatry 1984; 141:857-861.
  • Kent JM, Papp LA, Martinez JM, Browne ST, Coplan JD, Klein DF, et al. Specifity of panic response to CO2 inhala- tion in panic disorder: a comparison with major depression and premenstrual dysphoric disorder. Am J Psychiatry 2001; 158:58-67.
  • Klein DF. False suffocations alarms, spontaneous panics, and related conditions: an integrative hypothesis. Arch Gen Psychiatry 1993; 50:306-317.
  • Antony MM, Brown TA, Barlow DH. Response to hyperventilation and 5.5% carbon dioxide inhalation of subjects with types of specific phobia, panic disorder, or no mental illness. Am J Psychiatry 1997; 154:1089-1095.
  • Sakai Y, Kumano H, Nishikawa M, Sakano Y, Kaiya H, Imabayashi E, et al. Cerebral glucose metabolism associated with a fear network in panic disorder. Neuroreport 2005; 16:927-931.
  • van den Heuvel OA, Veltman DJ, Groenewegen HJ, Cath DC, van Balkom AJ, van Hartskamp J, et al. Frontal striatal dysfunction during planning in obsessive compulsive disorder. Arch Gen Psychiatry 2005; 62:301-309.
  • Yoo HK, Kim MJ, Kim SJ, Sung YH, Sim ME, Lee YS, et al. Putaminal gray matter volume decrease in panic disorder: an optimized voxel-based morphometry study. Eur J Neurosci 2005; 22:2089-2094.
  • Bremner JD, Innis RB, White T, Fujita M, Silbersweig D, Goddard AW, et al. SPECT Iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry 2000; 47:96-106.
  • Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, Jones T, Nutt DJ. Decreased brain GABA(A)-benzodiazepine re- ceptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry 1998; 55:715- 720.
  • Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D. Early coadministration of clonazepam with sertraline for panic disorder. Arch Gen Psychiatry 2001; 58:681-686.
  • Schneier FR, Liebowitz M, Abi-Dargham A, Zea-Ponce Y, Lin SH, Laruelle M. Low dopamine D(2) receptor binding potential in social phobia. Am J Psychiatry 2000; 157:457- 459.
  • Tiihonen J, Kuikka J, Rasanen P, Lepola U, Koponen H, Liuska A, et al. Cerebral benzodiazepine receptor binding and distribution in generalized anxiety: a fractal analysis. Mol Psychiatry 1997; 2:463-471.
  • Bell CJ, Malizia AL, Nutt DJ. The neurobiology of social phobia. Eur Arch Psychiatry Clin Neurosci 1999; 249(Suppl.1):S11-S19.
  • Phan KL, Fitzgerald DA, Nathan PJ, Tancer ME. Associa- tion between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol Psychiatry 2006; 59:424-429.
  • Tillfors M, Furmark T, Marteinsdottir I, Fischer H, Pissiota A, Langström B, et al. Cerebral blood flow in subjects with social phobia during stressful speaking tasks a PET study. Am J Psychiatry 2001; 158:1220-1226.
  • Amir N, Klumpp H, Elias J, Bedwell JS, Yanasak N, Miller LS. Increased activation of the anterior cingulated cortex during processing of disgust faces in individuals with social phobia. Biol Psychiatry 2005; 57:975-981.
  • Rauch SL, Wright I, Martis B, Busa E, McMullin KG, Shin LM, et al. A magnetic resonance imaging study of cortical thickness in animal phobia. Biol Psychiatry 2004; 55:946- 952.
  • Straube T, Kolassa IT, Glauer M, Mentzel HJ, Miltner WH. Effect of task conditions on brain responses to threatening faces in social phobics: an event-related functional magnetic resonance imaging study. Biol Psychiatry 2004; 56:921-930.
  • Szeszko PR, Robinson D, Alvir JM, Bilder RM, Lencz T, Ashtari M, et al. Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry 1999; 56:913-919.
  • Rosenberg DR, Keshavan MS, O’Hearn KM, Dick EL, Bagwell WW, Seymour AB, et al. Frontostriatal measure- ment in treatment-naive children with obsessive-compulsive disorder. Arch Gen Psychiatry 1997; 54:824-830.
  • Gilbert AR, Moore GJ, Keshavan MS, Paulson LA, Narula V, Mac Master FP, et al. Decrease of thalamic volumes in pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry 2000; 57:449- 456.
  • Valente AA Jr, Miguel EC, Castro CC, Amaro E Jr, Duran FL, Buchpiguel CA, et al. Regional gray matter abnormalities in obsessive compulsive disorder. Biol Psychiatry 2005; 58:479-487.
  • Swedo SE, Schapiro MB, Grady CL, Cheslow DL, Leonard HL, Kumar A, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989; 46:518-523.
  • Nakao T, Nakagawa A, Yoshiura T, Nakatani E, Nabeyama M, Yoshizato C, et al. Brain activation of patients with obsessive compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Biol Psychiatry 2005; 57:901-910.
  • Perani D, Colombo C, Bressi S, Bonfanti A, Grassi F, Scarone S, et al. FDG PET study in obsessive-compulsive disorder: a clinical/metabolic correlation study after treatment. Br J Psychiatry 1995; 166:244-250.
  • Rosenberg DR, Benazon NR, Gilbert A, Sullivan A, Moore GJ. Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral ther- apy. Biol Psychiatry 2000; 48:294-300.
  • Shin LM, Wright CA, Cannistraro PA, Wedig MM, McMullin K, Martis B, et al. A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry 2005; 62:273-281.
  • Kitayama N, Vaccarino C, Kutner M, Weiss P, Bremner JD. Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: a meta analysis. J Affect Disord 2005; 88:79-86.
  • Tupler LA, De Bellis MD. Segmented hippocampal volume in children and adolescents with posttraumatic stress disorder. Biol Psychiatry 2006; 59:523-529.
  • Woodward SH, Kaloupek DG, Streeter CC, Martinez C, Schaer M, Eliez S. Decreased anterior cingulated volume in combat related PTSD. Biol Psychiatry 2006; 59:582-587.
  • Aschenbrand SG, Kendall PC, Webb A, Safford SM, Flannery-Schroeder E. is childhood separation anxiety disorder a predictor of adult panic disorder and agoraphobia? A seven-year longitudinal study. J Am Acad Child Adolesc Psychiatry 2003; 42:1476-1485.
  • Waters AM, Mogg K, Bradley BP, Pine DS. Attentional bias for emotional faces in children with generalized anxiety disorder. J Am Acad Child Adolesc Psychiatry 2008; 47:435-442.
  • Aikins DE, Craske MG. Cognitive theories of generalized anxiety disorder. Psychiatric Clin North Am 2001; 24:57- 74.
  • Mennin DS, Heimberg RG, Turk CL, Fresco DM. Prelimi- nary evidence for an emotion dysregulation model of generalized anxiety disorder. Behav Res Ther 2005; 43:1281-1310.
  • Rinck M, Becker ES. A comparison of attentional biases and memory biases in women with social phobia and major depression. J Abnorm Psychol 2005; 114:62-74.
  • Stopa L, Clark DM. Social phobia and interpretation of so- cial events. Behav Res Ther 2000; 38:273-283.
  • Hofmann SG. Perception of control over anxiety mediates the relation between catastrophic thinking and social anxi- ety in social phobia. Behav Res Ther 2005; 43:885-895.
  • Radomsky AS, Rachman S. Memory bias in obsessive- compulsive disorder. Behav Res Ther 1999; 37:605-618.
  • Clayton IC, Richards JC, Edwards CJ. Selective attention in obsessive-compulsive disorder. J Abnorm Psychol 1999; 108:171-175.
  • Ehlers A, Clark DM. A cognitive model of posttraumatic stress disorder. Behav Res Ther 2000; 38:319-345.
  • Fyer AJ. Current approaches to etiology and pathophysiology of specific phobia. Biol Psychiatry 1998; 44:1295- 1304.
  • Peri T, Ben Shakhar G, Orr SP, Shalev AY. Psychophysio- logical assessment of aversive conditioning in posttraumatic stress disorder. Biol Psychiatry 2000; 47:512-519.
  • Bandelow B, Spath C, Tichauer GA, Broocks A, Hajak G, Rüther E. Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder. Compr Psychiatry 2002; 43:269-278.
  • Breslau N, Davis GC. Posttraumatic stress disorder in an urban population of young adults: risk factors for chronicity. Am J Psychiatry 1992; 149:671-675.
  • Roy-Byrne PP, Wagner A. Primary care perspectives on generalized anxiety disorder. J Clin Psychiatry 2004; 65(Suppl.13):20-26.
APA DOĞAN O (2012). The etiology of anxiety disorders. , 224 - 231.
Chicago DOĞAN ORHAN The etiology of anxiety disorders. (2012): 224 - 231.
MLA DOĞAN ORHAN The etiology of anxiety disorders. , 2012, ss.224 - 231.
AMA DOĞAN O The etiology of anxiety disorders. . 2012; 224 - 231.
Vancouver DOĞAN O The etiology of anxiety disorders. . 2012; 224 - 231.
IEEE DOĞAN O "The etiology of anxiety disorders." , ss.224 - 231, 2012.
ISNAD DOĞAN, ORHAN. "The etiology of anxiety disorders". (2012), 224-231.
APA DOĞAN O (2012). The etiology of anxiety disorders. Anadolu Psikiyatri Dergisi, 13(3), 224 - 231.
Chicago DOĞAN ORHAN The etiology of anxiety disorders. Anadolu Psikiyatri Dergisi 13, no.3 (2012): 224 - 231.
MLA DOĞAN ORHAN The etiology of anxiety disorders. Anadolu Psikiyatri Dergisi, vol.13, no.3, 2012, ss.224 - 231.
AMA DOĞAN O The etiology of anxiety disorders. Anadolu Psikiyatri Dergisi. 2012; 13(3): 224 - 231.
Vancouver DOĞAN O The etiology of anxiety disorders. Anadolu Psikiyatri Dergisi. 2012; 13(3): 224 - 231.
IEEE DOĞAN O "The etiology of anxiety disorders." Anadolu Psikiyatri Dergisi, 13, ss.224 - 231, 2012.
ISNAD DOĞAN, ORHAN. "The etiology of anxiety disorders". Anadolu Psikiyatri Dergisi 13/3 (2012), 224-231.
Sayfa Oluşturulma Tarihi
22-04-2024 19:52

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları